🔗 Visit the ClinicalTrials.gov page for NCT01561456
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Molecular pathways and therapeutic targets in lung cancer. | Oncotarget | 2014 | 1.16 |
| 2 | Targeted therapies in development for non-small cell lung cancer. | J Carcinog | 2013 | 1.12 |
| 3 | Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor. | Semin Oncol | 2013 | 1.03 |
| 4 | Modulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectives. | Oncol Rev | 2013 | 0.79 |
| 5 | Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma. | Leuk Lymphoma | 2014 | 0.78 |